Finance

Lists
Q1 2027 earnings • released • EPS beat +4.86% • Revenue beat +5.58%
See results
AARTIDRUGS:NSE
Aarti Drugs Ltd
₹407.60
-3.58%
(-15.15) 1D
Aug 3, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AARTIDRUGS...
Open
₹424.00
High
₹424.00
Low
₹405.00
Mkt. cap
37.20B
Avg. vol.
206.78K
Volume
383.24K
Dividend
0.49%
Quarterly dividend
₹0.50
Ex-dividend date
Feb 9, 2026
P/E ratio
19.08
52-wk high
₹534.55
52-wk low
₹318.95
EPS
₹21.36
Shares outstanding
23.58M
No. of employees
1K
Open
₹424.00
High
₹424.00
Low
₹405.00
Mkt. cap
37.20B
Avg. vol.
206.78K
Volume
383.24K
Dividend
0.49%
Quarterly dividend
₹0.50
Ex-dividend date
Feb 9, 2026
P/E ratio
19.08
52-wk high
₹534.55
52-wk low
₹318.95
EPS
₹21.36
Shares outstanding
23.58M
No. of employees
1K
News stories
From sources across the web
About Aarti Drugs Ltd
CEOPrakash M. Patil
Employees1.28K
Founded1984
Headquarters-
SectorPharmaceutical industry
Websiteaartidrugs.co.in
Last report
Just released
Today, 1:30 AM
Fiscal period
Q1 2027
EPS / Est. (INR)
₹5.66 / ₹5.40
+4.86%beat
Revenue / Est. (INR)
7.04B / 6.66B
+5.58%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.53B
6.02B
7.20B
7.04B
Cost of goods sold
4.08B
3.87B
4.50B
4.28B
Cost of revenue
4.08B
3.87B
4.50B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
330.70M
331.60M
322.80M
-
Operating expense
1.76B
1.77B
1.91B
-
Total operating expenses
5.85B
5.63B
6.42B
-
Operating income
681.20M
383.20M
785.20M
-
Other non operating income
-91.00K
16.00K
-45.00K
-
EBT including unusual items
604.11M
290.32M
703.56M
-
EBT excluding unusual items
604.11M
290.32M
703.56M
-
Income tax expense
152.50M
-115.20M
151.00M
191.10M
Effective tax rate
25.24%
-39.68%
21.46%
-
Other operating expenses
1.27B
1.26B
1.41B
-
Net income
452.80M
405.40M
551.90M
501.70M
Net profit margin
6.94%
6.74%
7.66%
7.13%
Earnings per share
4.95
-
-
5.66
Interest and investment income
-
-
-
-
Interest expense
-77.00M
-92.90M
-81.60M
-92.20M
Net interest expenses
-77.00M
-92.90M
-81.60M
-
Depreciation and amortization charges
162.60M
179.50M
180.40M
184.60M
EBITDA
836.10M
515.81M
952.62M
972.92M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps